Prof. (KR) Dr. med. Sven Lee

• Studium der Humanmedizin an der Johannes-Gutenberg-Universität Mainz
• Promotion an der Medizinischen Hochschule Hannover
• Mehr als 37.000 durchgeführte refraktive, chirurgische Operationen

Ab 2002
• Vorträge und wissenschaftliche Arbeiten in Deutschland, Europa, Asien, USA, China

Ab 2003
• Professor an der Chungang Universität Seoul, Korea, Klinik für Augenheilkunde, Abteilung “Katarakt und refraktive Chirurgie“

Ab 2004
• Panelist bei der ASCRS (American Society for Cataract and Refractive Surgery)

Ab 2017
• Shanghai New Vision Eye Ophthalmology Hospital

Ab 2020
• AUREGIO Tagesklinik Düsseldorf

Auszeichnungen
• ASCRS (American Society for Cataract and Refractive Surgery): Best Paper of Session, Keratorefractive Presbyopia: Laser Based: 2010
• ASCRS (American Society for Cataract and Refractive Surgery): Best Poster of Session, Keratorefractive Presbyopia: Intraocular surgery: 2010

Mitgliedschaften & Patentanmeldungen

• E.L.E.O.S (Excimer Laser European Ophthalmic Society): ab 2001.
• ESCRS (European Society of Cataract and Refractive Surgery, ASCRS (American Society of Cataract and Refractive Surgery), DOG (Deutsche Ophthalmologische Gesellschaft), SOE (European Society of Ophthalmology), AAO (American Academy of Ophthalmology), KSCRS (Korean Society of Cataract and Refractive Surgery, APAO (Asia-Pacific Academy of Ophthalmology Congress): ab 2002.
• Software Entwicklung (ASA80) eines Steueralgorithmus zur Veränderung der sphärischen Aberration (insbesondere Zernike Z(4,0) für den MEL80 Excimer Laser von Carl Zeiss Meditec, 2004.

wissenschaftliche Arbeiten / Publikationen

  • New Cooling techniques during PRK. ELEOS in Strasbourg, France. 2002
  • Painfree PRK with fast Visual Recovery. ASCRS in Philadelphia, USA. 2002
  • Painfree PRK with fast visual Recovery. AAO and ISRS in Orlando, USA. 2002
  • Cooling during PRK. AAO and ISRS in Orlando, USA. 2002
  • Cooling techniques during PRK. ESCRS in Nice, France. 2002
  • Painfree PRK with fast visual Recovery. ESCRS in Nice, France. 2002
  • Advanced Surface Ablation (ASA80) in Excimer Laser Refractive Surgery. ESCRS in Munich, Germany. 2003
  • “Das Trockene Auge“. 2003. Deutsche Gesundheitshilfe e.V.“
  • Comparison of First Clinical Results of the Advanced Surface Ablation (ASA80) with the MEL80 vs. MEL70. Zeiss Symposia in Munich, Germany. 2003
  • Manual for the MEL80: “Step by Step Manual for Advanced Surface Ablation”. Refractive Newsletter Carl Zeiss Meditec, 2003.
  • Where is the limit for successful and safe myopic surface ablation? Statistical analysis of 556 treated eyes”. Augenspiegel 2004
  • “Ein neues Therapiekonzept zur Behandlung des Trockenen Auges – Die Verwendung von Phospholipid-Liposomen“
  • Where is the limit for successful and safe Hyperopic Surface Ablation? Statistical analysis of 237 treated eyes. ESCRS in Barcelona, Spain. 2004
  • Where is the limit for successful and safe Myopic Surface Ablation? Statistical analysis of 556 treated eyes. ESCRS in Barcelona, Spain. 2004
  • Customized correction of spherical aberrations (Zernike (* 0)) with the Advanced Surface Ablation using the MEL80 (ASA80). ESCRS in Barcelona, Spain. 2004
  • “A New Therapy Concept with a Liposome Eye Spray for the Treatment of the Dry Eye”. Klinische Monatsblätter für Augenheilkunde, 2004.
  • Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 12 months follow-up. Zeiss Symposia in New Orleans, USA. 2004
  • Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 12 months follow-up. AAO and ISRS in New Orleans, USA. 2004
  • Wavefront guided correction of Presbyopia. ESCRS in Barcelona, Spain. 2004
  • Where is the limit for successful and safe myopic surface ablation? Statistical Analysis of 556 treated eyes. AAD in Duesseldorf, Germany. 2004
  • A new therapy concept with a liposome eye spray for the therapy of the „dry eye“. First clinical results of a statistical analysis of a long-term study. DOG in Berlin, Germany. 2004
  • Panelist in Session 2-J: Keratorefractive Epi-Lasik, Lasik, PRK. ASCRS in San Diego, USA. 2004
  • Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 2-9 months follow-up. ASCRS in San Diego, USA. 2004
  • Advanced Surface Ablation (ASA80). A new approach to Excimer-Laser-Surface Ablation for the correction of myopia. Statistical comparison with standard PRK. ASCRS in San Diego, USA. 2004
  • Where is the limit for successful and safe Myopic Surface Ablation? 3-Year-Follow-Up. Statistical analysis of 446 treated eyes. ASCRS in San Diego, USA. 2004
  • Where is the limit for successful and safe Hyperopic Surface Ablation? Statistical analysis of 237 treated eyes. ASCRS in San Diego, USA. 2004
  • Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 2-9 months follow-up. Zeiss Symposia in San Diego, USA. 2004
  • Customized correction of spherical aberrations (Zernike (* 0) with the Advanced Surface Ablation using the MEL80 (ASA80). Zeiss Symposia in Barcelona, Spain. 2004
  • Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 2-9 months follow-up. ESCRS in Paris, France. 2004
  • Advanced Surface Ablation (ASA80). A new approach to Excimer-Laser-Surface Ablation for the correction of myopia. Statistical comparison with standard PRK. ESCRS in Paris, France. 2004
  • Where is the limit for successful and safe Myopic Surface Ablation? 3-Year-Follow-Up. Statistical analysis of 446 treated eyes. ESCRS in Paris, France. 2004
  • Where is the limit for successful and safe Hyperopic Surface Ablation? Statistical analysis of 237 treated eyes. ESCRS in Paris, France. 2004
  • Comparative Study of Treatment of the Dry Eye Syndrome due to Disturbances of the Tear Film Lipid Layer with Lipid-Containing Tear Substitutes Efficacy of lipid-containing tear substitutes. ESCRS in Paris, France. 2004
  • Where is the limit for successful and safe hyperopic surface ablation? Statistical analysis of 237 treated eyes. Journal of the European Society of Cataract and Refractive Surgery, 2004.
  • Where is the limit for successful and safe Hyperopic Surface Ablation? Statistical analysis, Ocular Surgery News, 2004.
  • ASA80 (Advanced Surface Ablation using the MEL80) approach shows advantages over PRK. Ophthalmology Times, 2004.
  • Wavefront Guided Correction of Presbyopia with ASA80: 2 years follow up. Zeiss Symposia in Chicago, USA. 2005
  • “Therapie des Trockenen Auges“/ “Advances in the therapy of the Dry Eye Syndrome“, Ophthalmologische Nachrichten, 2005.
  • Advanced Surface Ablation (ASA80) today. International MEL80 Symposium in Bangkok, Thailand. 2005
  • Statistical Analysis of Presbyopia Treatments. International MEL80 Symposium in Bangkok, Thailand. 2005
  • Clinical aspects and patient selection for presbyopia treatments. International MEL80 Symposium in Bangkok, Thailand. 2005
  • Presbyopia Correction with the MEL * Statistical Analysis of Clinical Outcomes. AAO and ISRS in Chicago, USA. 2005
  • Complications and Treatment of Diabetic Retinopathia. DOG in Berlin, Germany. 2005
  • New Advances in Cataract Surgery today. DOG in Berlin, Germany. 2005
  • Where is the limit for successful and safe Myopic Surface Ablation? 3-Year-Follow-Up. Statistical analysis of 446 treated eyes. Ocular Surgery News, 2005
  • Wavefront guided correction of Contrast Sensitivity, Mesopic Contrast Sensitivity and Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80®). The 7th Refractive Symposium at the Catholic University in Seoul, Korea. 2005
  • Rigorous statistical analyses prove upper limit for safe, successful hyperopic PRK. Journal of the European Society of Cataract and Refractive Surgery, 2005.
  • Less Pain more gain with Advanced Surface Ablation. Journal of the European Society of Cataract and Refractive Surgery, 2005.
  • Improving Contrast Sensitivity with Shifting of the Spherical Aberration to Sustain Corneal Prolaticity. Refractive Newsletter Carl Zeiss Meditec, 2005.
  • Wavefront Guided Correction of Presbyopia – German Multicenter Statistical Analysis. Refractive Newsletter Carl Zeiss Meditec, 2006.
  • Wavefront Guided Correction of Presbyopia, Contrast Sensitivity and Mesopic Contrast Sensitivity: 2 Year Follow up. ASCRS in San Francisco, USA. 2006
  • Altering Zernike Polynomials to Correct Presbyopia and Quality of Vision Results (ASA80). ASCRS in San Francisco, USA. 2006
  • “Vergleichende Studie zur Therapie des Trockenen Auges bedingt durch Lipidphasenstörungen mit lipidhaltigen Tränenpräparaten. Zur Wirksamkeit lipidhaltiger Tränenpräparate”. “Comparative Study of Treatment of the Dry Eye Syndrome due to Disturbances of the Tear Film Lipid Layer with Lipid-Containing Tear Substitutes. Efficacy of lipid-containing tear substitutes”. Klinische Monatsblätter für Augenheilkunde, 2006
  • Panelist in Session 4-C: Wavefront, New Technology. ASCRS in San Francisco, USA. 2006
  • Comparative study of the therapy of dry eye syndrome with artificial tear substitutes especially for the treatment of the disturbance of the lipid layer. SOE Congress in Berlin, Germany. 2006
  • Comparative study of the therapy of dry eye syndrome with artificial tear substitutes especially for the treatment of the disturbance of the lipid layer. Chinese Academy of Sciences in Shanghai, China. 2006
  • Presbyopia Correction with the MEL80 Using ASA80®/ASA Lasek®: Statistical Analysis of clinical outcomes: 3 year follow-up of a Multicenter Study. Turkish Refractive Surgery Symposium in Antalya, Turkey. 2006
  • Correction of Presbyopia and Contrast Sensitivity with the MEL 80 Using ASA80®/ASA Lasek®: Statistical Analysis of clinical outcomes. 3 year follow-up of a Multicenter Study. APAO in Singapore, Singapore. 2006
  • New aspheric profiles with alternated Zernike Polynomials to improve Presbyopia and Night Vision Problems, esp. in high myopic patients with Advanced Surface Ablation (ASA-Lasek). ESCRS in Stockholm, Sweden. 2007
  • Wavefront Guided Correction of Presbyopia, Contrast Sensitivity, Mesopic Contrast Sensitivity with Advanced Surface Ablation (ASA80): 3 year follow-up. ESCRS in Stockholm, Sweden. 2007
  • Advanced Surface Ablation using a Spot-Scanning-Excimer Laser (ASA80): Statistical Comparison of results with standard laser profiles and new aspheric ablation profiles with altered Zernike Polynomials. ESCRS in Stockholm, Sweden. 2007
  • Creating monovision on the non-dominant eye for the correction of presbyopia by altering Zernike Polynomials. A new approach: 1 year follow-up. ESCRS in Berlin, Germany. 2008
  • Treatment of high myopia and hyperopia with wavefront-guided advanced-surface-ablation (ASA-Lasek®). Increasing the depth-of-field with aspheric-shoffiles: 2 year-follow-up. ESCRS in Berlin, Germany. 2008
  •  Wavefront-Guided Correction of Presbyopia, Contrast Sensitivity, and Mesopic Contrast Sensitivity with Advanced Surface Ablation: Four-Year Follow-up. ASCRS in Berlin, Germany. 2008
  • Design of New Aspheric Ablation Profiles with Modified Zernike Polynomials to Improve Presbyopia and Night Vision Problems. ASCRS in Chicago, USA. 2008
  • Panelist in Session 4-C: Wavefront, New Technology, ASCRS in Chicago, USA. 2008
  • Micromonovision on the non-dominant eye for the correction of presbyopia by altering Zernike Polynomials: new approach – 2 years follow-up. ESCRS in Barcelona, Spain. 2009
  • Presbyopia correction with AcrySof ReSTOR, CustomVue monovision, and wavefront-guided monofocal ablation: comparative analysis. ESCRS in Barcelona, Spain. 2009
  • Statistical comparison of presbyopia correction with wavefront-guided advanced surface ablation, CustomVue monovision LASIK, and multifocal ReSTOR IOLs. ESCRS in Barcelona, Spain. 2009
  • Correction of high refractive errors with wavefront-guided advanced-surface-ablation (ASA-LASEK): increasing the depth-of-field with aspheric-shoffiles- 3 year follow-up. ESCRS in Barcelona, Spain. 2009
  • Creating Micromonovision in the Nondominant Eye for the Correction of Presbyopia by Altering Zernike Polynomials: Eighteen-Month Follow-up. ASCRS in San Francisco, USA. 2009
  • Treatment of High Myopia and Hyperopia with Wavefront-Guided Advanced Surface Ablation Increasing the Depth-of-Field with Aspheric Shotfiles: Three-Year Follow-up. ASCRS in San Francisco, USA. 2009
  • Approaches to Presbyopia Correction: Comparative Analysis of Wavefront-Guided Monofocal Ablation, Multifocal IOLs, and Monovision: Two-Year Results. ASCRS in Boston, USA. 2010
  • Wavefront Correction of High Refractive Errors with Aspheric Shotfiles to Increase Depth-of-Field ASA LASEK: Three-Year Results. ASCRS in Boston, USA. 2010
  • Panelist in Session 2-O: Keratorefractive Surface Ablation, ASCRS in Boston, USA. 2010

Unsere Praxen

Auregio Vorteile

  • TÜV Zertifiziert
  • H+S Zertifiziert
  • BZH Zertifiziert
  • Medical Experts Düsseldorf
  • 9 Standorte in der Region
  • Ganzheitliche Beratung